Patient Recruitment: Accelerating Trial Enrollment With Data-Driven Outreach

Patient enrollment remains one of the most critical challenges in clinical trial execution, with difficulties in identifying eligible participants often leading to delays and increased costs. Strict inclusion and exclusion (I/E) criteria, limited patient awareness, and inefficiencies in outreach further complicate recruitment efforts. Quest Diagnostics addresses these challenges by leveraging its extensive clinical database of over 300 million patients to streamline patient identification and enhance enrollment strategies.

By utilizing de-identified clinical data, Quest determines the volume of patients meeting trial criteria, ensuring precise patient identification. Through targeted direct-to-patient outreach eligible participants receive clear trial information and direct access to sponsor recruitment pages for further screening. With HIPAA-compliant communication strategies, flexible pricing models, and data-driven patient identification, Quest enhances trial visibility, accelerates enrollment timelines, and reduces recruitment costs. Partnering with Quest ensures more efficient, patient-centric recruitment strategies, ultimately driving faster access to groundbreaking therapies.